IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Ricci, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.234
EU - Europa 4.189
AS - Asia 2.908
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 12
SA - Sud America 11
Totale 15.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.204
UA - Ucraina 1.465
CN - Cina 1.387
IT - Italia 643
DE - Germania 596
SG - Singapore 579
HK - Hong Kong 426
FI - Finlandia 385
PL - Polonia 355
IE - Irlanda 237
TR - Turchia 237
GB - Regno Unito 220
IN - India 204
FR - Francia 174
SE - Svezia 34
CA - Canada 29
ID - Indonesia 27
MU - Mauritius 24
BE - Belgio 16
EU - Europa 16
IR - Iran 14
RU - Federazione Russa 13
VN - Vietnam 12
AU - Australia 11
ES - Italia 9
NL - Olanda 9
CZ - Repubblica Ceca 7
JP - Giappone 7
RO - Romania 7
CI - Costa d'Avorio 4
MK - Macedonia 4
UG - Uganda 4
EC - Ecuador 3
EE - Estonia 3
MY - Malesia 3
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CL - Cile 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BR - Brasile 1
CH - Svizzera 1
GR - Grecia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 15.405
Salva come PNG Salva come JPEG
Città #
Fairfield 1.038
Jacksonville 1.012
Woodbridge 711
Ashburn 554
Houston 535
Chandler 451
Singapore 448
Princeton 445
Ann Arbor 426
Hong Kong 426
Cambridge 419
Wilmington 412
Nanjing 373
Seattle 358
Warsaw 353
New York 250
Dearborn 248
Dublin 234
Istanbul 209
Helsinki 194
Beijing 158
Nanchang 124
Des Moines 105
Milan 101
Shenyang 93
Brescia 92
Hebei 74
Jinan 72
Changsha 63
San Diego 56
Tianjin 55
Jiaxing 50
Shanghai 46
Kunming 41
Lancaster 37
Hangzhou 35
Verona 35
Boardman 30
Ningbo 29
San Francisco 28
Jakarta 27
Lanzhou 24
Munich 24
Los Angeles 22
Pune 22
Romola 21
San Mateo 21
Toronto 20
Zhengzhou 20
Springfield 18
Kocaeli 17
London 17
Augusta 16
Guangzhou 16
Rome 16
Leawood 15
Norwalk 15
Ardabil 13
Brussels 13
Changchun 13
Rozzano 13
Dong Ket 12
Hefei 12
Redwood City 12
Taiyuan 10
Taizhou 10
Fuzhou 9
Haikou 9
Monmouth Junction 9
Auburn Hills 8
Orange 8
Bologna 7
Casier 7
Indiana 7
Chiswick 6
Lambeth 6
Lappeenranta 6
Ottawa 6
Phoenix 6
Redmond 6
Stuttgart 6
Sydney 6
Tokyo 6
Gunzenhausen 5
Abidjan 4
Bergamo 4
Brno 4
Chicago 4
Florence 4
Melbourne 4
Mountain View 4
Mumbai 4
Paris 4
Parma 4
Santa Clara 4
Washington 4
Ankara 3
Bangalore 3
Berlin 3
Buccinasco 3
Totale 11.042
Salva come PNG Salva come JPEG
Nome #
Persistent intraepithelial lymphocytosis in celiac patients adhering to gluten-free diet is not abolished despite a gluten contamination elimination diet 246
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 224
Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet 209
A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy. 191
Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature. 151
13C-urea breath test values and Helicobacter pylori eradication. 142
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection:a randomised controlled trial 140
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 131
Ulcerative colitis and the aging-related development of colonic diverticula 131
Factors that contribute to hypertransaminasemia in patients with celiac disease or functional gastrointestinal syndromes 130
Helicobacter pylori infection: anything new should we know? 127
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. 125
Five year time course of celiac disease serology during gluten free diet: results of a community based " CD-Watch" program. 124
Absence of Helicobacter pylori in dental plaque assessed by stool test. 122
Age, Helicobacter pylori and/or CagA antibodies as a pre-endoscopic screening policy 120
A rapid Immunochromatographic assay for Helicobacter pylori in stool before and after treatment 119
Adalimumab in active ulcerative colitis: A "real-life" observational study. 119
Randomised clinical study: Gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity 118
A rapid, low dose 13C Urea tablet for the detection of Helicobacter pylori infection before and after treatment 114
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 112
Best cut off values for 14C-urea breath tests for Helicobacter pylori detection 110
A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 110
Diagnosis of Helicobacter pylori infection: which is the best test? Stool test 108
Editorial: Noncoeliac gluten sensitivity - The controversy rages on. Authors' reply 106
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease 105
High eradication rates for Helicobacter pylori with a new sequential treatment 104
Celiac disease with mild enteropathy is not mild disease 104
Letter: Gluten challenge in the era of noncoeliac gluten sensitivity - A change in clinical practice? Author's reply 104
Usefulness of serology in preendoscopic screening 102
Helicobacter pylori: storia e tassonomia 102
Diagnosis and treatment of Helicobacter. A 2002 Updated review 101
Non invasive antigen based assay for assessing Helicobacter pylori eradication. A European multicenter study 101
How valuable is the application on Consensus guidelines in the management of functional gastrointestinal disorders 99
Stool test for Helicobacter pylori 99
A serologic survey of Helicobacter pylori infection in 3281 patients endoscoped for upper gastrointestinal symptoms through Italia 99
POST-INFECTIOUS IRRITABLE BOWEL SYNDROME FOLLOWING A WATER BORNE nOROVIRUS-eNTEROVIRUS GASTROENTERITIS OUTBREAK. 99
Rifaximin suspension for the eradication of Helicobacter pylori 98
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 97
Helicobacter pylori: diseases, tests and treatment 97
Stool test for Helicobacter pylori 95
C-Urea Breath Test Values and Helicobacter pylori Eradication 95
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. 95
Clinical expression of lymphocytic duodenosis in "mild enteropathy" celiac disease and in functional gastrointestinal syndromes 95
The multidisciplinary team for management of inflammatory bowel diseases 93
IgG Elisa antibodies and detection of Helicobacter pylori in elderly patients 93
Peptic ulcer and Helicobacter pylori. 93
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 92
Disegno dello Studio e dati Preliminari del progetto SEELN (Steatosi Epatica non alcolica): Epidemiologia nutrizionale e Lifestyle Medicine 92
Blood tests in management of Helicobacter pylori infection 91
Symptoms and Helicobacter pylori, any link 90
Five year time course of celiac disease serology during gluten free diet: Results of a community based " CD-Watch" program 90
The Italian Registry of Therapeutic Apheresis: Granulocyte_Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease. A Multicentric Study 88
Exhaled nitric oxide as a marker of lung involvement in Crohns disease. 88
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 88
Newer agents for Helicobacter pylori eradication 86
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy 84
Helicobacter pylori status, endoscopic findings, and serology in HIV-1 -positive patients 84
Diagnosis of Helicobacter pylori infection: faecal antigen determination 83
A new self-administered semi-quantitative food frequency questionnaire to estimate nutrient intake among Italian adults: Development design and validation process 83
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 83
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 82
Gastroesophageal reflux disease and Barrett's esophagus. 82
Regional differences of mucosal hydrophobicity in the gastrointestinal tract of healthy subjects 82
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 81
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. 80
Duodenal histological features in suspected non-celiac gluten sensitivity: new insights into a still undefined condition 80
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance 79
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 78
Four years time course of celiac disease (CD) serology during gluten free diet (GFD) resluts of a community based program. 76
Incidence of post-infectious irritable bowel sydrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak 76
Potential celiac disease is not a mild disease: a single unit study in a color of 1140 patients 75
Accuracy of the stool antigen test in the pre- and post-eradication diagnosis of Helicobacter pylori infection, and in patients on omeprazole therapy 74
HLA gene dose effect and helicobacter pylori infection do not contribute to persistence od intraepithelial lymphocitosis frequently observed in celiac patients adherent to gluten free diet. 73
Helicobacter pylori infection, anti-CagA antibodies and peptic ulcer in 1,626 patients: a case control study in Italy 72
Are cardiovascular rik factors affected by gluten free diet in celiac patients? Results in a cohor of 765 patients. 72
Tissue transglutaminases antibodies (T-TGA) level as predictor of villous atrophy among adult unselected patients twith sispected celiac disease (CD 72
Diagnosis of Helicobacter pylori infection 71
Laser-assisted ratio analyser (LARA) versus isotope ratio mass spectrometry (IRMS): a comparative study using two doses of 13C-urea and two test meals for pre- and post-treatment diagnosis of Helicobacter pylori infection 71
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial. 71
A second-line anti-Helicobacter pylori in theray in patients with previously failed treatment 71
Persistence of intraepithelial lymphocytosis in celiac patietns adherent to gluten free diet: is there a HLA gene dose effec or a role for Helicobacter pylori infection ? 71
Accurate diagnosis of Helicobacter pylori: stool tests 70
Is severity of duodenal histopatology morrored by differences in clinical and laboratory presentation in celiac disease ? A single unit study in a cohort of 1140 patients. 70
Amoxicillin-clavulanate-induced ischaemic colitis 70
Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery. 69
CARDIOVASCULAR RISK FACTORS ARE AFFECTED BY GLUTEN FREE DIET (GFD) IN CELIAC DISEASE (CD): RESULTS IN A COHORT OF 765 PATIENTS. 69
HLA gene dose effect does not contribute to persistence of intraepithelial lymphocytosis frequently observed in celiac patientis adherent to gluten free diet. 69
Authors' replay: Comment to "High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease" 69
Evaluation of systo-diastolic cardiac function and arterial stiffness in subjects with new diagnosis of coeliac disease without cardiovascular risk factors. 69
Celiac dsease at the time of dianosis: age-relted differences in clinical, serological and histopathological features 68
Is villous atrophy predictable by high tissue-transglutaminases antibodies (T-Tga) level in unselected adult patients evaluated for celiac disease (CD) ? 68
Postinfectious functional intestinal disorders following a waterborn norovirus gastroenteritis our break 68
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: A pilot study 68
Celiac diseases at the time of diagosis in a cohort of 793 patietnts: age-related differences in clinical, serological and histopathogogical features. 67
Increased serum gammaglutamyltranspeptidase activity: a surrogate marker of non alcoholic hepatic steatosis in chronic hepatitis C? . 67
Novel steps forward in the histopathology of non-celiac gluten sensitivity, authors’ reply 67
Celiac disease in the elderly: clinical, serological and histological characteristics, and effect of gluten free diet 66
five years time-course of transglutaminases (t-TG) antibodies and adherence to gluten free population based program. 66
A Prospective Clinical Trial on Safety and Efficacy of Antiviral Treatment of Chronic Hepatitis C in Active Illicit Drug Users 66
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 66
Totale 9.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.360 0 0 0 0 0 504 366 415 180 480 151 264
2020/20212.717 64 298 91 297 105 302 69 375 449 235 363 69
2021/20221.643 71 299 24 117 30 77 62 129 93 188 184 369
2022/20231.465 258 32 45 100 111 433 5 132 207 12 68 62
2023/20241.763 86 38 81 161 97 381 71 50 445 33 27 293
2024/20251.030 33 34 36 429 484 14 0 0 0 0 0 0
Totale 15.679